{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:41:04Z","timestamp":1789382464289,"version":"build-2803163510"},"reference-count":39,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T00:00:00Z","timestamp":1743292800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Major Science and Technology Special Project of Yunnan Province (Biomedicine)","award":["202202AA100006"],"award-info":[{"award-number":["202202AA100006"]}]},{"name":"Major Science and Technology Special Project of Yunnan Province (Biomedicine)","award":["202201AT070236"],"award-info":[{"award-number":["202201AT070236"]}]},{"name":"Major Science and Technology Special Project of Yunnan Province (Biomedicine)","award":["2021-I2M-1-043"],"award-info":[{"award-number":["2021-I2M-1-043"]}]},{"name":"Major Science and Technology Special Project of Yunnan Province (Biomedicine)","award":["202002AA100009"],"award-info":[{"award-number":["202002AA100009"]}]},{"name":"Major Science and Technology Special Project of Yunnan Province (Biomedicine)","award":["2024SKLDRS0101"],"award-info":[{"award-number":["2024SKLDRS0101"]}]},{"name":"Major Science and Technology Special Project of Yunnan Province (Biomedicine)","award":["3332022075"],"award-info":[{"award-number":["3332022075"]}]},{"name":"Science and Technology Project of Yunnan Province\u2014General Program","award":["202202AA100006"],"award-info":[{"award-number":["202202AA100006"]}]},{"name":"Science and Technology Project of Yunnan Province\u2014General Program","award":["202201AT070236"],"award-info":[{"award-number":["202201AT070236"]}]},{"name":"Science and Technology Project of Yunnan Province\u2014General Program","award":["2021-I2M-1-043"],"award-info":[{"award-number":["2021-I2M-1-043"]}]},{"name":"Science and Technology Project of Yunnan Province\u2014General Program","award":["202002AA100009"],"award-info":[{"award-number":["202002AA100009"]}]},{"name":"Science and Technology Project of Yunnan Province\u2014General Program","award":["2024SKLDRS0101"],"award-info":[{"award-number":["2024SKLDRS0101"]}]},{"name":"Science and Technology Project of Yunnan Province\u2014General Program","award":["3332022075"],"award-info":[{"award-number":["3332022075"]}]},{"name":"CAMS Innovation Fund for Medical Sciences (CIFMS)","award":["202202AA100006"],"award-info":[{"award-number":["202202AA100006"]}]},{"name":"CAMS Innovation Fund for Medical Sciences (CIFMS)","award":["202201AT070236"],"award-info":[{"award-number":["202201AT070236"]}]},{"name":"CAMS Innovation Fund for Medical Sciences (CIFMS)","award":["2021-I2M-1-043"],"award-info":[{"award-number":["2021-I2M-1-043"]}]},{"name":"CAMS Innovation Fund for Medical Sciences (CIFMS)","award":["202002AA100009"],"award-info":[{"award-number":["202002AA100009"]}]},{"name":"CAMS Innovation Fund for Medical Sciences (CIFMS)","award":["2024SKLDRS0101"],"award-info":[{"award-number":["2024SKLDRS0101"]}]},{"name":"CAMS Innovation Fund for Medical Sciences (CIFMS)","award":["3332022075"],"award-info":[{"award-number":["3332022075"]}]},{"name":"Yunnan Province Innovative Vaccine Technology","award":["202202AA100006"],"award-info":[{"award-number":["202202AA100006"]}]},{"name":"Yunnan Province Innovative Vaccine Technology","award":["202201AT070236"],"award-info":[{"award-number":["202201AT070236"]}]},{"name":"Yunnan Province Innovative Vaccine Technology","award":["2021-I2M-1-043"],"award-info":[{"award-number":["2021-I2M-1-043"]}]},{"name":"Yunnan Province Innovative Vaccine Technology","award":["202002AA100009"],"award-info":[{"award-number":["202002AA100009"]}]},{"name":"Yunnan Province Innovative Vaccine Technology","award":["2024SKLDRS0101"],"award-info":[{"award-number":["2024SKLDRS0101"]}]},{"name":"Yunnan Province Innovative Vaccine Technology","award":["3332022075"],"award-info":[{"award-number":["3332022075"]}]},{"name":"Industrial Transformation Platform","award":["202202AA100006"],"award-info":[{"award-number":["202202AA100006"]}]},{"name":"Industrial Transformation Platform","award":["202201AT070236"],"award-info":[{"award-number":["202201AT070236"]}]},{"name":"Industrial Transformation Platform","award":["2021-I2M-1-043"],"award-info":[{"award-number":["2021-I2M-1-043"]}]},{"name":"Industrial Transformation Platform","award":["202002AA100009"],"award-info":[{"award-number":["202002AA100009"]}]},{"name":"Industrial Transformation Platform","award":["2024SKLDRS0101"],"award-info":[{"award-number":["2024SKLDRS0101"]}]},{"name":"Industrial Transformation Platform","award":["3332022075"],"award-info":[{"award-number":["3332022075"]}]},{"name":"State Key Laboratory of Drug Regulatory Science Project","award":["202202AA100006"],"award-info":[{"award-number":["202202AA100006"]}]},{"name":"State Key Laboratory of Drug Regulatory Science Project","award":["202201AT070236"],"award-info":[{"award-number":["202201AT070236"]}]},{"name":"State Key Laboratory of Drug Regulatory Science Project","award":["2021-I2M-1-043"],"award-info":[{"award-number":["2021-I2M-1-043"]}]},{"name":"State Key Laboratory of Drug Regulatory Science Project","award":["202002AA100009"],"award-info":[{"award-number":["202002AA100009"]}]},{"name":"State Key Laboratory of Drug Regulatory Science Project","award":["2024SKLDRS0101"],"award-info":[{"award-number":["2024SKLDRS0101"]}]},{"name":"State Key Laboratory of Drug Regulatory Science Project","award":["3332022075"],"award-info":[{"award-number":["3332022075"]}]},{"name":"Fundamental Research Funds for the Central Universities","award":["202202AA100006"],"award-info":[{"award-number":["202202AA100006"]}]},{"name":"Fundamental Research Funds for the Central Universities","award":["202201AT070236"],"award-info":[{"award-number":["202201AT070236"]}]},{"name":"Fundamental Research Funds for the Central Universities","award":["2021-I2M-1-043"],"award-info":[{"award-number":["2021-I2M-1-043"]}]},{"name":"Fundamental Research Funds for the Central Universities","award":["202002AA100009"],"award-info":[{"award-number":["202002AA100009"]}]},{"name":"Fundamental Research Funds for the Central Universities","award":["2024SKLDRS0101"],"award-info":[{"award-number":["2024SKLDRS0101"]}]},{"name":"Fundamental Research Funds for the Central Universities","award":["3332022075"],"award-info":[{"award-number":["3332022075"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Background: We performed a phase I experiment in a healthy teenage population in Sui County, Henan Province, China. The trial was randomized, double-blind, and placebo-controlled. Methods: Ninety-six adolescents were randomly assigned in three groups (high-dose, medium-dose, and low-dose) to receive a dose of the vaccine or the placebo. The patients were monitored for adverse events (AEs) for up to 30 days after each dose of the vaccine and for up to 6 months after all doses of serious AEs (SAEs). All observed AEs and SAEs were reported. Microneutralization assays were used to measure geometric mean titers (GMTs) and seroconversion rates for neutralizing antibodies. IgA and IgG antibodies specific to the rotavirus were detected. Results: The rates of total AEs in these groups were 8.33%, 37.50%, 12.50%, and 4.17%, respectively. The neutralizing antibody test revealed that the teenage groups with low, medium, and high doses of the vaccine had geometric mean titers of 424.32, 504.63, and 925.45, respectively, at 28 days following complete vaccination. The GMT of serum IgG at final immunization was 6501.86, 6501.82, and 10,173.3, in the low-dose, medium-dose, and high-dose groups, respectively. The GMT of serum IgA at final immunization was 2733.64, 2233.29, and 3596.66 in the low-dose, medium-dose group, and high-dose groups, respectively. Conclusions: The majority of adverse events (AEs) were deemed Grade 1 or 2, suggesting that the vaccine\u2019s safety profile is suitable for healthy adolescents. For the primary immunogenicity endpoints, a preliminary examination of the GMTs and the positive transfer rate of neutralizing antibodies in the different experimental groups revealed that, in adolescents aged 6\u201317, the high-dose group displayed significantly higher levels of neutralizing antibodies compared to the medium- and low-dose groups. Adolescents had few side effects from the new inactivated rotavirus vaccination, and it elicited an immune response.<\/jats:p>","DOI":"10.3390\/vaccines13040369","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T05:10:07Z","timestamp":1743397807000},"page":"369","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety and Immunogenicity of a New Rotavirus-Inactivated Vaccine in the Chinese Adolescent Population: A Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial"],"prefix":"10.3390","volume":"13","author":[{"given":"Yan","family":"Liu","sequence":"first","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102629, China"},{"name":"State Key Laboratory of Drug Regulatory Science, Beijing 102629, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangwei","family":"Feng","sequence":"additional","affiliation":[{"name":"Henan Center for Disease Control and Prevention, Zhenzhou 450016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6125-1821","authenticated-orcid":false,"given":"Jinyuan","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Kunming 650118, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinling","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Kunming 650118, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Pu","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Kunming 650118, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Wang","sequence":"additional","affiliation":[{"name":"Henan Center for Disease Control and Prevention, Zhenzhou 450016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangyang","family":"You","sequence":"additional","affiliation":[{"name":"Henan Center for Disease Control and Prevention, Zhenzhou 450016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yin","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Kunming 650118, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Yi","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Kunming 650118, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiebing","family":"Tan","sequence":"additional","affiliation":[{"name":"Henan Center for Disease Control and Prevention, Zhenzhou 450016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Lin","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Kunming 650118, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Huang","sequence":"additional","affiliation":[{"name":"Henan Center for Disease Control and Prevention, Zhenzhou 450016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Gao","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102629, China"},{"name":"State Key Laboratory of Drug Regulatory Science, Beijing 102629, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingchuan","family":"Yu","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102629, China"},{"name":"State Key Laboratory of Drug Regulatory Science, Beijing 102629, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiumeng","family":"Tong","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102629, China"},{"name":"State Key Laboratory of Drug Regulatory Science, Beijing 102629, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102629, China"},{"name":"State Key Laboratory of Drug Regulatory Science, Beijing 102629, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Kunming 650118, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Hu","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Kunming 650118, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ye","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Kunming 650118, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjing","family":"Kuang","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Kunming 650118, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Kunming 650118, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyu","family":"Hu","sequence":"additional","affiliation":[{"name":"National Institutes for Food and Drug Control, Beijing 102629, China"},{"name":"State Key Laboratory of Drug Regulatory Science, Beijing 102629, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Henan Center for Disease Control and Prevention, Zhenzhou 450016, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Li","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Chinese Academy of Medical Science & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Disease, Kunming 650118, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.vaccine.2022.12.008","article-title":"Review of the health impact of the oral rotavirus vaccine program in children under 5 years in Australia: 2006\u20132021","volume":"41","author":"Middleton","year":"2023","journal-title":"Vaccine"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/21645515.2020.1770035","article-title":"Rotavirus vaccination and intussusception: A paradigm shift?","volume":"17","author":"Vetter","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e210356","DOI":"10.1001\/jamapediatrics.2021.0356","article-title":"Rotavirus Vaccines-Going Strong After 15 Years","volume":"175","author":"Bernstein","year":"2021","journal-title":"JAMA Pediatr."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Zhou, X., Wang, Y., Chen, N., Pang, B., Liu, M., Cai, K., and Kobayashi, N. (2023). Surveillance of Human Rotaviruses in Wuhan, China (2019\u20132022): Whole-Genome Analysis of Emerging DS-1-like G8P [8] Rotavirus. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241512189"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/cid\/ciz060","article-title":"Global Review of the Age Distribution of Rotavirus Disease in Children Aged <5 Years Before the Introduction of Rotavirus Vaccination","volume":"69","author":"Ladva","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.1093\/infdis\/jiaa598","article-title":"The Rotavirus Vaccine Story: From Discovery to the Eventual Control of Rotavirus Disease","volume":"224","author":"Glass","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Carcamo-Calvo, R., Munoz, C., Buesa, J., Rodriguez-Diaz, J., and Gozalbo-Rovira, R. (2021). The Rotavirus Vaccine Landscape, an Update. Pathogens, 10.","DOI":"10.3390\/pathogens10050520"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12519-022-00546-0","article-title":"Regional hospitalisation and seasonal variations of Pediatric rotavirus gastroenteritis pre- and post-RV vaccination: A prospective and retrospective study","volume":"18","author":"Barsoum","year":"2022","journal-title":"World J. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jinf.2018.07.004","article-title":"Prevalence of rotavirus and rapid changes in circulating rotavirus strains among children with acute diarrhea in China, 2009\u20132015","volume":"78","author":"Yu","year":"2019","journal-title":"J. Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.vaccine.2022.11.074","article-title":"Cost-benefit analysis of rotavirus vaccine included in the national immunization program in China","volume":"41","author":"Chen","year":"2023","journal-title":"Vaccine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1016\/j.vaccine.2020.04.038","article-title":"Efficacy, immunogenicity and safety of a trivalent live human-lamb reassortant rotavirus vaccine (LLR3) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial","volume":"38","author":"Xia","year":"2020","journal-title":"Vaccine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1080\/21645515.2020.1804245","article-title":"Product review of the rotavirus vaccines ROTASIIL, ROTAVAC, and Rotavin-M1","volume":"17","author":"Skansberg","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1016\/j.vaccine.2019.03.069","article-title":"Effectiveness of Lanzhou lamb rotavirus vaccine in preventing gastroenteritis among children younger than 5 years of age","volume":"37","author":"Li","year":"2019","journal-title":"Vaccine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4161\/hv.26476","article-title":"The human rotavirus vaccine Rotarix in infants: An integrated analysis of safety and reactogenicity","volume":"10","author":"Buyse","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.virs.2022.07.011","article-title":"Efficacy, safety and immunogenicity of hexavalent rotavirus vaccine in Chinese infants","volume":"37","author":"Wu","year":"2022","journal-title":"Virol. Sin."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S1473-3099(21)00473-4","article-title":"Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: A randomised, double-blind, four-arm parallel group dose-ranging study","volume":"22","author":"Witte","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40264-021-01141-4","article-title":"Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception","volume":"45","author":"Singh","year":"2022","journal-title":"Drug Saf."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1097\/INF.0000000000003286","article-title":"Do Rotavirus Strains Affect Vaccine Effectiveness? A Systematic Review and Meta-analysis","volume":"40","author":"Cates","year":"2021","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.12688\/wellcomeopenres.16174.2","article-title":"Effectiveness of Rotarix ((R)) vaccine in Africa in the first decade of progressive introduction, 2009\u20132019: Systematic review and meta-analysis","volume":"5","author":"Murunga","year":"2020","journal-title":"Wellcome Open Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e032549","DOI":"10.1136\/bmjopen-2019-032549","article-title":"The ORVAC trial protocol: A phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis","volume":"9","author":"Middleton","year":"2019","journal-title":"BMJ Open"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1016\/j.vaccine.2019.05.069","article-title":"A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC(R) in comparison with a licensed rotavirus vaccine in healthy infants","volume":"37","author":"Ella","year":"2019","journal-title":"Vaccine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1442-200x.2000.01249.x","article-title":"Child rotavirus infection in association with acute gastroenteritis in two Chinese sentinel hospitals","volume":"42","author":"Fang","year":"2000","journal-title":"Pediatr. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/INF.0000000000003463","article-title":"Rotavirus Infection in Children < 5 Years of Age in Suzhou, China, 2013-2019: Disease Burden, Genotype Distribution and Seasonality","volume":"41","author":"Shen","year":"2022","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e181382","DOI":"10.1001\/jamanetworkopen.2018.1382","article-title":"Rotavirus Gastroenteritis Infection Among Children Vaccinated and Unvaccinated With Rotavirus Vaccine in Southern China: A Population-Based Assessment","volume":"1","author":"Fu","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s00705-013-1663-1","article-title":"Rotavirus infection and its genetic characterization in non-hospitalized adults with acute gastroenteritis in Shanghai, China","volume":"158","author":"Shen","year":"2013","journal-title":"Arch. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"001782","DOI":"10.1099\/jgv.0.001782","article-title":"ICTV Virus Taxonomy Profile: Sedoreoviridae 2022","volume":"103","author":"Matthijnssens","year":"2022","journal-title":"J. Gen. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00705-011-1006-z","article-title":"Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG)","volume":"156","author":"Matthijnssens","year":"2011","journal-title":"Arch. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1016\/j.vaccine.2024.05.014","article-title":"A randomized, double-blind, placebo-controlled phase I clinical trial of rotavirus inactivated vaccine (Vero cell) in a healthy adult population aged 18-49 years to assess safety and preliminary observation of immunogenicity","volume":"42","author":"Wu","year":"2024","journal-title":"Vaccine"},{"key":"ref_29","unstructured":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) (2021, March 09). Integrated addendum to ICH E6(R1): Guideline for Good Clinical Practice E6(R2). Available online: https:\/\/ich.org."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"A114","DOI":"10.1016\/j.vaccine.2011.07.118","article-title":"A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children","volume":"30","author":"Dang","year":"2012","journal-title":"Vaccine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.vaccine.2012.12.020","article-title":"A phase I clinical trial of a new 5-valent rotavirus vaccine","volume":"31","author":"Luna","year":"2013","journal-title":"Vaccine"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1080\/21645515.2020.1861874","article-title":"Safety and immunogenicity of a novel oral hexavalent rotavirus vaccine: A phase I clinical trial","volume":"17","author":"Wu","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.47102\/annals-acadmedsg.V45N2p44","article-title":"Efficacy, Immunogenicity and Safety of a Human Rotavirus Vaccine RIX4414 in Singaporean Infants","volume":"45","author":"Phua","year":"2016","journal-title":"Ann. Acad. Med. Singap."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1080\/21645515.2015.1085143","article-title":"Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants","volume":"12","author":"Li","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4161\/hv.26319","article-title":"Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: A randomized, placebo-controlled trial in China","volume":"10","author":"Li","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(22)00161-X","article-title":"Safety and immunogenicity of the Rotavac and Rotasiil rotavirus vaccines administered in an interchangeable dosing schedule among healthy Indian infants: A multicentre, open-label, randomised, controlled, phase 4, non-inferiority trial","volume":"22","author":"Kanungo","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41541-022-00443-7","article-title":"Microneedle patch as a new platform to effectively deliver inactivated polio vaccine and inactivated rotavirus vaccine","volume":"7","author":"Moon","year":"2022","journal-title":"NPJ Vaccines"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Resch, T.K., Wang, Y., Moon, S.S., Joyce, J., Li, S., Prausnitz, M., and Jiang, B. (2018). Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice. Sci. Rep., 8.","DOI":"10.1038\/s41598-017-18973-9"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1016\/j.vaccine.2010.06.006","article-title":"Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets","volume":"28","author":"Wang","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/4\/369\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:05:50Z","timestamp":1760029550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/4\/369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,30]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["vaccines13040369"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13040369","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,30]]}}}